Report overview
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
This report aims to provide a comprehensive presentation of the global market for Over The Counter (OTC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over The Counter (OTC) Drugs. This report contains market size and forecasts of Over The Counter (OTC) Drugs in global, including the following market information:
Global Over The Counter (OTC) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Over The Counter (OTC) Drugs market was valued at US$ 159420 million in 2022 and is projected to reach US$ 216090 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Analgesics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Over The Counter (OTC) Drugs include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Over The Counter (OTC) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Over The Counter (OTC) Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Over The Counter (OTC) Drugs Market Segment Percentages, by Type, 2022 (%)
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Global Over The Counter (OTC) Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Over The Counter (OTC) Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Global Over The Counter (OTC) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Over The Counter (OTC) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Over The Counter (OTC) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Over The Counter (OTC) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Over The Counter (OTC) Drugs, market overview.
Chapter 2: Global Over The Counter (OTC) Drugs market size in revenue.
Chapter 3: Detailed analysis of Over The Counter (OTC) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Over The Counter (OTC) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
